MEDICINAL LUNG INJURY: CLINICAL OBSERVATION
https://doi.org/10.17650/1818-8338-2011-2-68-71
Abstract
Presented clinical case is a classical version of «amiodarone lung» in patient taking inadequate doses of the drug, probably, according to the scenario of acute clinical course
About the Authors
N. A. Karoli
Razumovsky Saratov State University, Ministry of Health and Social Development of Russia
Russian Federation
Department of Hospital Therapy
Russian Federation
Department of Hospital Therapy
A. P. Rebrov
Razumovsky Saratov State University, Ministry of Health and Social Development of Russia
Russian Federation
Department of Hospital Therapy
Russian Federation
Department of Hospital Therapy
E. E. Arkhangelskaya
Razumovsky Saratov State University, Ministry of Health and Social Development of Russia
Russian Federation
Department of Hospital Therapy
Russian Federation
Department of Hospital Therapy
R. N. Steshenko
Regional Hospital, Saratov
Russian Federation
Division of Pulmonology
Russian Federation
Division of Pulmonology
A. S. Bukia
Regional Hospital, Saratov
Russian Federation
Division of Pulmonology
Russian Federation
Division of Pulmonology
N. V. Dvornikova
Regional Hospital, Saratov
Russian Federation
Division of Pulmonology
Russian Federation
Division of Pulmonology
References
1. Интерстициальные болезни легких: Практическое руководство. Под ред. Н.А. Мухина. М.: Литтерра, 2007.
2. Рейнольдс Г. Интерстициальные заболевания легких. В кн.: Внутренние болезни по Тинсли Р. Харрисону в 7 книгах. Книга 4. Болезни сердца и сосудов. Болезни органов дыхания. Болезни почек и мочевых путей. Под ред. Э. Фаучи, Ю. Браунвальд, К. Иссельбахер, et al. М.: Практика, 2005.
3. Ben-Noun L. Drug-induced respiratory disorders: incidence, prevention and management. Drug Saf 2000;23(2):143–64.
4. Boggess K.A., Benedetti T.J., Raghu G. Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature. Obstet Gynecol Surv 1996;51(6):367–70.
5. Camus P., Foucher P., Bonniaud P., et al. Drug-unduced infiltrative lung disease. Eur Respir J 2001;32:93–100.
6. Cockroft D.W., Fisher K.L. Near normalization of spirometry in a subject with emphysema complicated by amiodarone lung. Respir Med 1999;93:597–600.
7. Cox G., Johnson J., Kinnear W.J., et al. Amiodarone and the lung toxic variations in clinical practice. Respir Med 2000;94:1130–1.
8. Dimopoulou L., Marathias K., Daganou M., et al. Low dose amiodarone related complications after cardiac operations. J Thorac Cardiovasc Surg 1997;114:31–7.
9. Donaldson L., Grant L.S., Naysmith M.R., et al. Amiodarone pulmonary toxicity. Amiodarone should be
10. used with caution in patients in intensive care. BMJ 1997;314:1832.
11. Liverani E., Armuzzi A., Mormile F., et al. Amiodarone-induced adult respiratory distress-syndrome after nonthoracotomy subcutaneous defibrillator implants. J Internal Med 2001;249:565–6.
12. Bedrossian C.W., Warren C.J., Ohar J., Bhan R. Amiodarone pulmonary toxicity: cytopathology, ultrastructure and immunocytochemistry. Ann Diagn Pathol 1997;1:47–56.
Review
For citations:
Karoli N.A., Rebrov A.P., Arkhangelskaya E.E., Steshenko R.N., Bukia A.S., Dvornikova N.V. MEDICINAL LUNG INJURY: CLINICAL OBSERVATION. The Clinician. 2011;5(2):68-71. (In Russ.) https://doi.org/10.17650/1818-8338-2011-2-68-71
Views:
889
Email this article 